Evidence map›Paper›PMID 41994253›Full record

ArticleReproductive medicine and biology

Letrozole Reduces Ovulatory Responsiveness in In Vitro-Grown Mouse Follicles.

Tatsuya Kobayashi, Hiroshi Ishikawa, Hirokazu Tanaka, Kumiko Ishii, Akira Mitsuhashi, Hirokazu Usui, Makio Shozu, Kaori Koga

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tatsuya KobayashiResearch Promotion Unit, School of Medical Sciences Fujita Health University Tokyo Japan.ORCID https://orcid.org/0000-0001-5072-6756
Hiroshi IshikawaDepartment of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0003-1116-6885
Hirokazu TanakaSaisei Hospital Chiba Japan.
Kumiko IshiiDepartment of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine Chiba University Chiba Japan.
Akira MitsuhashiDepartment of Obstetrics and Gynecology, School of Medicine Dokkyo Medical University Tochigi Japan.ORCID https://orcid.org/0000-0003-3948-9256
Hirokazu UsuiDepartment of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0002-4331-6043
Makio ShozuDepartment of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0002-7247-2205
Kaori KogaDepartment of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0002-5057-4120

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to determine whether continuous aromatase inhibition with letrozole reduces peri-ovulatory responsiveness to ovulatory stimulation in in vitro-grown mouse follicles. Methods: Early antral follicles were isolated from 21 to 24-day-old C57BL/6jjcl mice and cultured individually for 5 days with letrozole (0.01, 0.1, or 1 μM) or vehicle. Follicle survival and growth were assessed by measuring follicle diameter. Ovulatory responsiveness was evaluated by hCG/EGF stimulation. Expression of ovulation-related genes ( Results: Letrozole did not affect follicle survival or growth. However, ovulation rates were reduced in a dose-dependent manner ( Conclusions: Continuous letrozole exposure reduces ovulatory responsiveness in in vitro-grown mouse follicles and is associated with decreased Lhcgr expression after hCG stimulation, likely due to estrogen deficiency. These findings suggest that prolonged aromatase inhibition during follicular growth may impair acquisition of peri-ovulatory competence.

Indexed as

breast cancer; letrozoleluteinizing hormone/chorionic gonadotropin receptorovulation

Identifiers

PMID41994253
PMCPMC13081686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.